| PACKAGING TYPE: | 1x30 C-box |
| COMPOSITION: | Salmeterol(50mcg) & Fluticasone Propionate(250mcg) |
| FORMULATION: | Capsule |
| Description: | SALTEROL 250 Rotacap is a combination inhalation therapy containing Salmeterol 50 mcg, a long-acting bronchodilator (LABA), and Fluticasone Propionate 250 mcg, a corticosteroid. It is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Salmeterol provides prolonged bronchodilation by relaxing airway muscles, while Fluticasone reduces inflammation in the lungs. This dual-action therapy helps in improving breathing, reducing exacerbations, and maintaining long-term respiratory control, delivered effectively via rotacap inhalation. |
| Side Effects: | Headache Tremors Palpitations Throat irritation Oral fungal infection (thrush) Rare: allergic reactions |
| How to Use: | Use with a compatible rotahaler device as prescribed Insert the rotacap into the inhaler device Inhale deeply through the mouthpiece Do not swallow the capsule Rinse mouth after use to prevent oral infections Follow proper inhalation technique |
| Precaution: | Rinse mouth after use to prevent oral infections Not intended for immediate relief of acute asthma attacks Use under medical supervision Avoid exceeding prescribed dosage Inform doctor about other medications or health conditions Regular monitoring may be required for long-term therapy |
| Product Benefits: | Provides long-lasting bronchodilation Reduces airway inflammation effectively Improves lung function and breathing Helps prevent asthma attacks and COPD exacerbations Ensures targeted delivery through rotacap inhalation Suitable for long-term mainten |
Frequently Asked Questions
It is used for maintenance treatment of asthma and COPD.
Salmeterol provides long-acting bronchodilation, while Fluticasone reduces airway inflammation.
No, it is not meant for immediate relief of acute asthma attacks.










